5-MAPDI (also known as Indanylmethylaminopropane or IMP) is an entactogenic amphetamine derivative which is structurally related to MDMA as well as to dihydrobenzofuran derivatives such as 5-MAPDB and 6-MAPDB, and has been sold as a designer drug. It has reportedly been sold over grey-market websites since around 2014, although the first definitive identification was not made until September 2016 by a forensic laboratory in Slovenia.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - 5-MAPDI (en)
- 5-MAPDI (es)
|
rdfs:comment
| - 5-MAPDI (also known as Indanylmethylaminopropane or IMP) is an entactogenic amphetamine derivative which is structurally related to MDMA as well as to dihydrobenzofuran derivatives such as 5-MAPDB and 6-MAPDB, and has been sold as a designer drug. It has reportedly been sold over grey-market websites since around 2014, although the first definitive identification was not made until September 2016 by a forensic laboratory in Slovenia. (en)
- 5-MAPDI (también conocido como indanilmetilaminopropano o IMP) es un derivado de anfetamina entactogénico que está relacionado estructuralmente con MDMA así como con derivados de dihidrobenzofurano como y , y se ha vendido como fármaco de diseño. Según se informa, se ha vendido en sitios web del mercado gris desde alrededor de 2014, aunque la primera identificación definitiva no se realizó hasta septiembre de 2016 por un laboratorio forense en Eslovenia. (es)
|
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
ATC prefix
| |
c
| |
CAS number
| |
ChemSpiderID
| |
H
| |
IUPAC name
| |
molecular weight
| |
n
| |
PubChem
| |
SMILES
| |
StdInChI
| |
StdInChIKey
| - MHBKJTHGGWQKSG-UHFFFAOYSA-N (en)
|
UNII
| |
has abstract
| - 5-MAPDI (also known as Indanylmethylaminopropane or IMP) is an entactogenic amphetamine derivative which is structurally related to MDMA as well as to dihydrobenzofuran derivatives such as 5-MAPDB and 6-MAPDB, and has been sold as a designer drug. It has reportedly been sold over grey-market websites since around 2014, although the first definitive identification was not made until September 2016 by a forensic laboratory in Slovenia. (en)
- 5-MAPDI (también conocido como indanilmetilaminopropano o IMP) es un derivado de anfetamina entactogénico que está relacionado estructuralmente con MDMA así como con derivados de dihidrobenzofurano como y , y se ha vendido como fármaco de diseño. Según se informa, se ha vendido en sitios web del mercado gris desde alrededor de 2014, aunque la primera identificación definitiva no se realizó hasta septiembre de 2016 por un laboratorio forense en Eslovenia. (es)
|
gold:hypernym
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
CAS number
| |
FDA UNII code
| |
PubChem
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is foaf:primaryTopic
of | |